Skip to content
2000
Volume 27, Issue 40
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background: Imidazo[2,1-b]thiazole, a well-known fused five-membered hetrocycle is one of the most promising and versatile moieties in the area of medicinal chemistry. Derivatives of imidazo[2,1-b]thiazole have been investigated for the development of new derivatives that exhibit diverse pharmacological activities. This fused heterocycle is also a part of a number of therapeutic agents. Objective: To review the extensive pharmacological activities of imidazo[2,1-b]thiazole derivatives and the new molecules developed between 2000-2018 and their usefulness. Method: Thorough literature review of all relevant papers and patents was conducted. Conclusion: The present review, covering a number of aspects, is expected to provide useful insights in the design of imidazo[2,1-b]thiazole-based compounds and would inspire the medicinal chemists for a comprehensive and target-oriented information to achieve a major breakthrough in the development of clinically viable candidates.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867326666190729152440
2020-12-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867326666190729152440
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test